HMP Education will organized six independent satellite symposia at JADPRO Live in 2022. Additional information including faculty and accreditation information is linked below. You can click the links to claim your credits.

Links to Session Faculty and Accreditation Information

Leveraging Bruton Tyrosine Kinase Inhibitors for the Treatment of CLL/SLL: Seeking Improved Outcomes

Strategies for the Optimal Management of NSCLC: A Focus on EGFR Mutations

Treatment Advances with Novel Anti-Androgen Therapy For Hormone-Sensitive and Castration-Resistant Prostate Cancer

Optimizing Treatment Strategies for Bladder Cancer: Incorporating Treatment Selection, Sequencing, and AE Management

Current and Emerging Treatment Strategies in Multiple Myeloma

CAR T-Cell Therapy in Hematologic Malignancies: Clinical Applications and Strategies for Optimal Outcomes

Commercial Support

All events have been supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Leveraging Bruton Tyrosine Kinase Inhibitors for the Treatment of CLL/SLL: Seeking Improved Outcomes has been supported by BeiGene and Pharmacyclics LLC, an AbbVie Company.

Optimizing Treatment Strategies for Bladder Cancer: Incorporating Treatment Selection, Sequencing, and AE Management has been supported by an independent educational grant from Astellas and Seagen Inc.

Current and Emerging Treatment Strategies in Multiple Myeloma has been supported by an independent educational grant from Karyopharm Therapeutics, Inc.